CN108503564A - A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride - Google Patents

A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride Download PDF

Info

Publication number
CN108503564A
CN108503564A CN201711010252.2A CN201711010252A CN108503564A CN 108503564 A CN108503564 A CN 108503564A CN 201711010252 A CN201711010252 A CN 201711010252A CN 108503564 A CN108503564 A CN 108503564A
Authority
CN
China
Prior art keywords
reaction
mivacurium chloride
formula
alkene
octyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711010252.2A
Other languages
Chinese (zh)
Inventor
魏文国
王亚军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Garnor Kang Pharmaceutical Co Ltd
Original Assignee
Wuhan Garnor Kang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Garnor Kang Pharmaceutical Co Ltd filed Critical Wuhan Garnor Kang Pharmaceutical Co Ltd
Publication of CN108503564A publication Critical patent/CN108503564A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the synthesis technical fields of medical compounds, specifically disclose a kind of improved Mivacurium Chloride intermediate suitable for industrialized production and the method using intermediate synthesis Micoud chloramines.This method is that Mivacurium Chloride is prepared by two-step reaction in starting material with pungent 4 alkene, 1,8 diacid of E and (R) (+) 5' methoxyl group laudanosines.This method starting material is cheap and easy to get, is extracted by liquid separation after first step reaction and the simple post-processing steps such as concentration, second step can obtain the product of 98% or more purity by simple extraction or mashing.The technological reaction and post-processing operation are simple, and acquired product quality is high, and requirement can be met by being not required to be further purified.The invented technology is simple and practical, is extremely suitable for industrial production.

Description

A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride
Technical field
The invention belongs to the synthesis technical fields of medical compounds, in particular it relates to which a kind of being suitable for industrial metaplasia The Mivacurium Chloride intermediate of production and the method for synthesizing Mivacurium Chloride using the intermediate.
Background technology
Mivacurium Chloride is by Abbott lab exploitations, in a kind of short-acting benzylisoquinoline in U.S.'s Initial Public Offering in 1992 Class nondepolarizer, clinically mainly as general anesthesia adjuvant, flesh pine is rapid-action (2 minutes) after intravenous, the duration Short (15 minutes), with dosage increase and work it is rapid, but acting duration extend it is few, when usual amounts to cardiovascular system without It influences, promotes histamine release effect smaller, on intracranial pressure and intraocular pressure without influence, for trachea cannula and maintain flesh pine, drug Using rapid-action, action time is short, restores rapid, no cumulative effect is few to vegetative nerve and cardiovascular adverse reaction.Micoud Oronain belongs to benzyl isoquinoline compound, and chemical structural formula is as follows:
The preparation method of Mivacurium Chloride is it is known in the art that such as EP0181055A1 discloses 6,7- dimethoxys -2- Methyl-1-(3,4,5- trimethoxyphenyls)-1,2,3,4- tetrahydroisoquinolines are obtained by fractionation, quaternization and three steps of esterification Mivacurium Chloride, reaction equation are as follows:
Mivacurium Chloride is the mixture and E- for the isomers 6A ︰ 6B=3 ︰ 1 of compound shown in formula 6 by ratio in the technique Octyl- 4- alkene -1,8- diacid reactants obtain Mivacurium Chloride, and final product Mivacurium Chloride includes three isomers, respectively (1R, 1'R, 2S, 2'S)-Mivacurium Chloride 5A, (1R, 1'R, 2R, 2'S)-Mivacurium Chloride 5B and (1R, 1'R, 2R, 2'R)-Mivacurium Chloride 5C, Middle Isomers content must satisfy:The content of 5C accounts for the 4%-8% of three isomers (5A, 5B and 5C) total contents;5A and 5B The sum of content accounts for the 92%-96% of three isomers (5A, 5B and 5C) total contents.The isomers of compound shown in intermediate formula 6 The ratio of 6A and 6B determines the active ingredient ratio of Mivacurium Chloride, also determines the impurity composition of technique.
Since compound shown in intermediate formula 6 is quaternary ammonium salt, it is easy to the moisture absorption and goes bad, it is very bad in industrial processes It preserves and weighs, and due to being a mixture (the isomers 6A and 6B of compound shown in formula 6), conventional recrystallization and excessively column Equal way of purification are all not applicable, can only be beaten solvent and be purified with by way of extracting and washing, produced eventually to a step below The purifying of object Mivacurium Chloride is brought a lot of trouble.
In compound shown in second step formula 6 and E- octyl- 4- alkene -1,8- diacid reactants, in the prior art by E- octyl- 4- alkene - 1,8- diacid becomes acyl chloride reaction, has used thionyl chloride, it is desirable that reaction is stringent anhydrous, equipment and operation are required it is high, and And post-reaction treatment purifies also troublesome complexity.
The second step process is improved in technical solution disclosed in WO2013021398A2, using N, N'- dicyclohexyls carbon two The mode being condensed under the conditions of acid imide DCC/4- dimethylamino naphthyridines DMAP is reacted, and the method is instead of reagents such as thionyl chlorides It uses, keeps reaction condition more safety mild.Wherein N, N'- dicyclohexylcarbodiimide and 4-dimethylaminopyridine structural formula It is as follows:
But genotoxicity impurity 4-dimethylaminopyridine and N, bis- rings of N'- are introduced in the synthesis of final step final product Hexyl carbon imidodicarbonic diamide.And genotoxicity impurity limit in bulk pharmaceutical chemicals quality analysis is extremely low, which post-processes band to product Come very big drawback, while by-product N, the N'- dicyclohexylurea (DCU) of N, N'- dicyclohexylcarbodiimide extremely easy to produce it is residual It stays, it is very difficult to remove.
The applicant is the study found that the preparation method of Mivacurium Chloride seldom has been reported that both at home and abroad, for depositing in the prior art Deficiency, new be suitable for industrialized production, economical and practical preparation method the present invention is intended to provide a kind of.
Invention content
High, the mild suitable industry easy to operate of reaction condition that the purpose of the present invention is to provide a kind of finished product purity and yields The Mivacurium Chloride key intermediate of production and the method for synthesizing Micoud chloramines using the intermediate.Present invention firstly provides one kind Mivacurium Chloride key intermediate, is bis- propyl propionate of compound E- octyl- 4- alkene -1,8- shown in formula 3, and structural formula is as follows:
In formula 3, X F, Cl, Br, I, methanesulfonyloxy group OMs or tolysulfonyl oxygroup OTos, preferably Cl or methane Sulfonyloxy;Wherein methanesulfonyloxy group and tolysulfonyl oxygroup structural formula is as follows:
Further, the present invention provides the preparation methods of bis- propyl propionate of the alkene -1,8- of compound E- octyl- 4- shown in formula 3:With E- 2 compound of octyl- 4- alkene -1,8- diacid and formula (3 halogenated or the substitution of class halogen propyl alcohol) is raw material, carries out condensation reaction generation Ester, reaction route are as follows:
The E- octyl- 4- alkene -1,8- diacid (1 compound of formula) in non-protonic solvent, condensing agent effect under with formula 2 React is condensed into ester to compound (propanol compound of halogenated or class halogen substitution), controls temperature of reaction system 0~100 DEG C, monitoring raw material disappears to get to the system containing product E-bis- propyl propionate of octyl- 4- alkene -1,8-, is then washed by simple extraction Or mashing, it is concentrated to give bis- propyl propionate crude product of E- octyl- 4- alkene -1,8-;
Alternatively, not using condensing agent in above-mentioned reaction, but first E- octyl- 4- alkene -1,8- diacid is reacted with thionyl chloride Become carrying out condensation reaction with 2 compound of formula again after acyl chlorides;
The condensing agent is selected from 1- (3- dimethylamino-propyls) -3- ethyl-carbodiimide hydrochlorides EDCl, N, bis- rings of N'- In hexyl carbon imidodicarbonic diamide DCC and N, N'- diisopropylcarbodiimides DIC any one or it is two or more:
The aprotic solvent is selected from ether, ethyl acetate, tetrahydrofuran, dimethyl-tetrahydrofuran, dioxane, methyl Tertbutyl ether, glycol dimethyl ether, glycol monoethyl ether, ethylene glycol diethyl ether, ethylene glycol monoethyl ether, dichloromethane and three chloromethanes One or more of alkane;
The aprotic solvent is preferably one or more of dichloromethane, ethyl acetate and tetrahydrofuran;
Compound shown in the formula 2 is selected from 3- chloropropyl alcohols, 3- iodine propyl alcohol, 3- bromopropyl alcohols, p-methyl benzenesulfonic acid 3- hydroxypropyl acrylates One or more of with Loprazolam 3- hydroxypropyl acrylates;
Compound shown in the formula 2 is preferably 3- chloropropyl alcohols and/or Loprazolam 3- hydroxypropyl acrylates;
E- octyl-s 4- alkene -1,8- diacid and 2 compound mole ratio of formula is 1 ︰ 2~1 ︰ 6, preferably 1: 2.2~1: 4;Instead Answer temperature control at 0~100 DEG C, preferably 0~30 DEG C;Reaction time is 0.5~24 hour, preferably 0.5~8 hour.
Further, the present invention also provides synthesized using above-mentioned bis- propyl propionate of E- octyl-s 4- alkene -1,8- (3 compound of formula) The method of Mivacurium Chloride, steps are as follows:
Bis- propyl propionate of E- octyl- 4- alkene -1,8- and (R)-(+) -5'- methoxyl group laudanosines in reaction dissolvent, temperature control 50~ After 100 DEG C are stirred 1~24 hour, HPLC monitors reaction raw materials and disappears, cold filtration, and resin anion (R.A.) (717 chlorine are added in filtrate Type), agitation and filtration, filtrate is spin-dried for obtaining crude compound shown in formula 5, and then by extracting concentration, i.e. obtaining purity reaches 98% Above Mivacurium Chloride.
When the X in 3 compound of formula is F, Cl, Br or methanesulfonyloxy group, sodium iodide is added and promotes reaction;
The reaction dissolvent is selected from least one of acetonitrile, propionitrile, dioxane, 2- butanone and acetone, preferably Acetonitrile.
Two propyl propionates of E- octyl- 4- alkene -1,8- are 1: 2~1 with (R)-(+) -5'- methoxyl group laudanosine molar ratios: 6, preferably 1: 2~1: 4;Reaction temperature is preferably 60~90 DEG C;Mixing time is preferably 8~16 hours.
The route that technical solution of the present invention synthesizes Mivacurium Chloride is as follows:
Compared to the prior art, it is with advantageous effect the advantages of technical solution provided by the invention:
1, the preparation method of Mivacurium Chloride provided by the invention, specifically with E- octyl-s 4- alkene -1,8- diacid and 3 it is halogenated or The propyl alcohol of person's class halogen substitution is that starting material obtains compound shown in intermediate formula 3 by condensation reaction, by simple purification, Compound shown in the formula 3 of high-purity just can be obtained, then flowing back under the conditions of acetonitrile equal solvent with compound shown in formula 4 can obtain To target product, by-product easily can be obtained qualification due to differing larger with product characteristics by simple extraction washing Bulk pharmaceutical chemicals.
2, the raw material of bis- propyl propionates of compound E- octyl- 4- alkene -1,8- shown in formula 3 of the present invention is easy to get, it is only necessary to simple Extracting and washing or distillation may be used in next step, and without severe toxicity, pollution is few for reaction;It reacts and easy to operate, low energy consumption, technique It is environmentally protective.
3, the present invention prepares the method starting material stabilization of Mivacurium Chloride, quality controllable, easy to maintain, is all single chemical combination Object.Ground without original be difficult to purify in technique and preserve, the intermediate mixture of the easy moisture absorption.
4, the method for Mivacurium Chloride prepared according to the methods of the invention, three reacted in the final product Mivacurium Chloride of gained are different Structure body (5A, 5B and 5C) component ratio meets the drug original and grinds requirement to bulk pharmaceutical chemicals:The content of 5C account for three isomers (5A, 5B and 5C) total content 4%-8%;The sum of 5A and 5B contents account for the 92%- of three isomers (5A, 5B and 5C) total contents 96%, the final product of stable quality can be obtained.
In short, technical solution provided by the invention does not use compound shown in formula 6, and directly use propyl ester and laudanosine (4 compound of formula 3 and formula) is reacted, and post-processing is routine operation, and unexpectedly has the technical effect that in final product three kinds The content of isomers meets original than relationship and grinds requirement.
The additional aspect and advantage of the present invention are set forth in part in the description, and will partly become from following describe Obviously, or through the invention practice is recognized.
Description of the drawings
Fig. 1:The HNMR collection of illustrative plates of two -3- chlorine propyl ester of E- octyl- 4- alkene -1,8- diacid obtained by 1 step 1 of embodiment.
Fig. 2:The HNMR collection of illustrative plates of Mivacurium Chloride obtained by 1 step 2-1 of embodiment.
Specific implementation mode
Applicant will be described in the embodiment of the present invention below, it should be noted that the embodiments described below is example Property, it is only used for explaining the present invention, and be not considered as limiting the invention.In addition, if do not clearly stated, below Embodiment employed in all reagents be commercially available in the market, or be referred to document or known method and close At, also it is what those skilled in the art were easy to get for the reaction condition that do not list.
In embodiment, the preparation method of Loprazolam 3- hydroxypropyl acrylates is as follows:
Add into the there-necked flask equipped with 1,3-PD (5g, 65.71mmol) and triethylamine (13.8mL, 98.56mmol) Enter 100mL dichloromethane, in N2It is cooled to 0 DEG C under protection, methane sulfonyl chloride (6.1mL, 31.03mmol) is added dropwise, is stirred at 0 DEG C 1 hour, after TLC contact plates show that the reaction was complete, water is added and is quenched, then three times with dichloromethane extraction (3 × 10mL), have Machine mutually uses anhydrous Na2SO4It is spin-dried for obtaining crude product after drying, in use, direct plungeing into reaction.
The preparation method of p-methyl benzenesulfonic acid 3- hydroxypropyl acrylates is as follows:
100mL triethylamines, N are added into 76g (1.0mol) 1,3-PDs and 150mL dichloromethane2The lower cooling of protection It to 0 DEG C, is added dropwise in paratoluensulfonyl chloride 95g (0.50mol) to above-mentioned solution, is stirred overnight at room temperature, the display of TLC contact plates has been reacted Quan Hou, decompression are spin-dried for, and the dissolving of 800mL dichloromethane is added, and organic phase uses 150mL water, 1mol/L dilute hydrochloric acid 150mL to wash successively It washs.After organic phase anhydrous Na2SO4It is spin-dried for obtaining crude product after drying, in use, direct plungeing into reaction.
A kind of synthetic method of 1 Mivacurium Chloride of embodiment, includes the following steps:
Step 1:Condensation reaction
5.0g E- octyl- 4- alkene -1,8- diacid is added in 25mL thionyl chlorides, is heated to reflux 3 hours, reaction finishes It is cooled to room temperature, is dissolved, be then slowly dropped at 0 DEG C or so dissolved with 5.6g 3- chloropropyl alcohols with 50mL dichloromethane after being spin-dried for 60mL dichloromethane in, reacted 10 hours at 25 DEG C after being added dropwise.Contact plate detects, and reaction finishes, and 50mL 1M hydrogen-oxygens are added Change sodium and reaction is quenched, after liquid separation, organic phase is dried with anhydrous sodium sulfate, is spin-dried for obtaining compound E- octyl- 4- alkene -1,8- diacid Two -3- chlorine propyl ester 8.3g (yield 86%) pale yellowish oil liquid, purity 95.6%.
HNMR(CDCl3)δ5.41(2H,m),4.16(4H,m),3.56(4H,m),2.31(4H,m),2.25(4H,m), 2.03(4H,m).
MS(ESI)m/z 326.2.3(M+1)。
Step 2-1:The synthesis (acetonitrile as solvents) of Mivacurium Chloride
By 4.1g (R)-(+) -5'- methoxyl groups laudanosine, 1.5g sodium iodides and 1.7g E- octyl- 4- alkene -1,8- diacid two - 3- chlorine propyl ester is added in 50mL acetonitriles, is heated to 60 DEG C and is flowed back 16 hours, and the reaction was complete for HPLC detections, is cooled to room temperature, mistake Filter, filter cake are washed with 5mL acetonitriles.Filtrate is dissolved after being spin-dried for 200mL methanol, and resin anion (R.A.) (717 chlorine type) 41g is added, stirs It mixes 3 hours.Filter out resin.Filtrate is spin-dried for obtaining yellow foam crude product 5.3g.50mL water and 50mL bis- are added into crude product Chloromethanes stirs liquid separation, and product enters water phase, and water phase is washed three times with dichloromethane (25mL × 3), and 18g NaCl are then added, Be added dichloromethane (100mL × 2) be extracted twice, dichloromethane mutually use 5m/v% (5g/100mL) NaCl solution (30mL × 2) it washes twice, is spin-dried for obtaining 4.5g (yield 79%) colourless foam sterling, product purity amounts to 98.98%.
MS(ESI)m/z 514.3(M/2)。
Step 2-1 products are detected through nuclear-magnetism.
Step 2-2:The synthesis of Mivacurium Chloride (2- butanone makees solvent)
By 4.1g (R)-(+) -5'- methoxyl groups laudanosine, 1.5g sodium iodides and 1.7g E- octyl- 4- alkene -1,8- diacid two - 3- chlorine propyl ester is added in 50mL 2- butanone, is heated to 60 DEG C and is flowed back 16 hours, and HPLC detections have 6.2% (R)-(+) -5'- Methoxyl group laudanosine raw material remains, and is cooled to room temperature, and filters, and filter cake is washed with 50mL 2- butanone.Merging filtrate adds after being spin-dried for Enter the dissolving of 200mL methanol.Then resin anion (R.A.) (717 chlorine type) 41g is added, stirs 3 hours, filters out resin, filtrate is spin-dried for Obtain yellow foam crude product 3.2g.50mL water and 50mL dichloromethane are added into crude product, stirs liquid separation, product enters water Phase, water phase are washed three times with dichloromethane (25mL × 3), and 18g NaCl are then added, and dichloromethane (100mL × 2) is added and extracts Twice, dichloromethane is mutually washed twice with the NaCl solution (30mL × 2) of 5m/v% (5g/100mL), is spin-dried for obtaining 2.3g (receipts Rate 40.3%) colourless foam sterling, product purity amounts to 98.47%.
MS(ESI)m/z 514.3(M/2)。
Step 2-2 products are detected through nuclear-magnetism.
Isomers content in above-mentioned steps 2-1 and step 2-2 products therefroms is measured and (uses HPLC, similarly hereinafter), And compared with bulk pharmaceutical chemicals ingredient in former triturate, and former triturate Comparative result is as follows:
The prior art is studies have shown that the ingredient with medicine effect is trans- trans isomer 5A and cis- in Mivacurium Chloride drug Trans isomer 5B, three kinds of isomers each component contents are most when testing result comparison finds that reaction dissolvent is acetonitrile, in products therefrom It is ground close to original, drug quality is best, and the result is most important to the quality of Mivacurium Chloride bulk pharmaceutical chemicals.
A kind of synthetic method of 2 Mivacurium Chloride of embodiment, includes the following steps:
Step 1:Condensation reaction
5g E- octyl- 4- alkene -1,8- diacid is added in 25mL thionyl chlorides, is heated to reflux 3 hours, reaction finishes cold But it to room temperature, is dissolved, is then slowly dropped at 0 DEG C or so dissolved with 33.5g 3- iodine propyl alcohol with 50mL dichloromethane after being spin-dried for In 100mL tetrahydrofurans, reacted 24 hours at 0 DEG C after being added dropwise.The reaction was complete for HPLC detections, and 50mL 1M hydroxides are added Reaction is quenched in sodium.After liquid separation, organic phase is dried with anhydrous sodium sulfate.It is spin-dried for obtaining compound E- octyl- 4- alkene -1,8- diacid two - 3- iodine propyl ester 12.1g (yield 81.6%) pale yellowish oil liquid, purity 95.3%.
HNMR(CDCl3)δ5.41(2H,m),4.11(4H,m),3.19(4H,m),2.34(4H,m),2.28(4H,m), 2.10(4H,m)
MS(ESI)m/z 509.2(M+1)。
Step 2:The synthesis of Mivacurium Chloride
Two -3- iodine propyl ester of 4g E- octyl- 4- alkene -1,8- diacid, 23.2g (R)-(+) -5'- methoxyl group laudanosines are added to It in 300mL propionitrile, is heated to 90 DEG C and flows back 8 hours, the reaction was complete for HPLC detections, is cooled to room temperature, and filters, filter cake 30mL third Nitrile washs.Resin anion (R.A.) (717 chlorine type) 40g is added into filtrate, stirs 5 hours, filters out resin, filtrate is spin-dried for obtaining Huang Color foam-like crude product 8.4g.50mL water and 50mL dichloromethane are added into crude product, stirs liquid separation, water phase dichloromethane (25mL × 3) are washed three times, and chloroform (10mL × 1) is washed once, and 18g NaCl are then added, and dichloromethane (100mL × 2) is added and extracts It takes twice, dichloromethane extract liquor merges, and is spin-dried for obtaining 6.5g (yield 75%) white foam sterling, purity 98.7%.
MS(ESI)m/z 514.3(M/2)。
Step 2 product is detected through nuclear-magnetism.
Isomers content in step 2 products therefrom is measured, and former triturate Comparative result is as follows:
A kind of synthetic method of 3 Mivacurium Chloride of embodiment, includes the following steps:
Step 1:Condensation reaction
5g E- octyl-s 4- alkene -1,8- diacid and 12.3g 3- iodine propyl alcohol are added in 60mL dichloromethane, are then added 12g 1- (3- dimethylamino-propyls) -3- ethyl-carbodiimide hydrochlorides and 3.5g 4-dimethylaminopyridine are reacted at 100 DEG C 0.5 hour, the reaction was complete for HPLC detections, 50mL 1mol/L dilute hydrochloric acid is added, reaction is quenched.After liquid separation, organic phase is eaten with saturation Brine (50mL × 2) washes twice, anhydrous sodium sulfate drying.It is spin-dried for obtaining two -3- iodine of compound E- octyl- 4- alkene -1,8- diacid Propyl ester 10.6g (yield 71.8%) pale yellowish oil liquid, purity 94.5%.
MS(ESI)m/z 509.2(M+1)。
Step 1 product is detected through nuclear-magnetism and is confirmed.Step 2:The synthesis of Mivacurium Chloride
Two -3- iodine propyl ester of 4g E- octyl- 4- alkene -1,8- diacid, 15.5g (R)-(+) -5'- methoxyl group laudanosines are added to It in 200mL acetonitriles, is heated to 50 DEG C and flows back 24 hours, the reaction was complete for HPLC detections, is cooled to room temperature, and filters, filter cake 40mL Acetonitrile washs.Resin anion (R.A.) (717 chlorine type) 40g is added into filtrate, stirs 5 hours.Filter out resin.Filtrate is spin-dried for obtaining Yellow foam crude product 10.5g.100mL water and 50mL dichloromethane are added into crude product, stirs liquid separation, water phase uses dichloro successively Methane (25mL × 2) is washed twice, and chloroform (10mL × 1) is washed once, then addition 27g NaCl, addition dichloromethane (100mL × 2) it is extracted twice, dichloromethane extract liquor merges, and is spin-dried for obtaining 7.1g (yield 82%) white foam sterling, purity 99.1%, 1- (3- dimethylamino-propyls) -3- ethyl carbamide contents are less than 6 μ g/mg.
MS(ESI)m/z 514.3(M/2)。
Step 2 product is detected through nuclear-magnetism.
Isomers content in 2 products therefrom of above-mentioned steps is measured, and former triturate Comparative result is as follows:
A kind of synthetic method of 4 Mivacurium Chloride of embodiment, includes the following steps:
Step 1:Condensation reaction
3.0g E- octyl- 4- alkene -1,8- diacid and 5.9g Loprazolam 3- hydroxypropyl acrylates are added to 100mL methyl tertbutyls In ether, 7.8g N, N'- dicyclohexylcarbodiimides and 1.05g 4-dimethylaminopyridine is then added, reaction 8 is small at 30 DEG C When, the reaction was complete for HPLC detections, 50mL 1mol/L dilute hydrochloric acid is added, reaction is quenched.After liquid separation, organic phase saturated salt solution (50mL × 2) wash twice, anhydrous sodium sulfate drying.It is spin-dried for obtaining compound E- octyl- 4- alkene -1,8- two-sulfonyl methanes of diacid Methyl tertiary butyl ether(MTBE) 100mL mashing is added in propyl ester crude product 6.4g, is filtered to remove N, N'- dicyclohexylurea (DCU)s.It is spin-dried for obtaining compound E- octyl- 4- alkene -1,8- diacid two-sulfonyl methane propyl ester 4.9g (yield 63.6%), pale yellowish oil liquid, purity 95.3%.
MS(ESI)m/z 445.5(M+1)。
Step 1 product is detected through nuclear-magnetism and is confirmed.
Step 2:The synthesis of Mivacurium Chloride
By 4.4g E- octyl- 4- alkene -1,8- two-sulfonyl methanes of diacid propyl ester, 4.95g sodium iodides and 8.5g (R)-(+) -5'- Methoxyl group laudanosine is added in 100mL acetone, is heated to 50 DEG C and is flowed back 10 hours, and the reaction was complete for HPLC detections, is cooled to room Temperature, filtering, filter cake are washed with 20mL acetone.Resin anion (R.A.) (717 chlorine type) 50g is added into filtrate, stirs 5 hours.Filtering Fall resin.Filtrate is spin-dried for obtaining yellow foam crude product 10.5g.50mL water and 50mL dichloromethane, stirring are added into crude product Liquid separation, water phase are washed three times with dichloromethane (25mL × 3) successively, and chloroform (10mL × 1) is washed once.Then 18g NaCl are added, Dichloromethane (100mL × 2) is added to be extracted twice.Dichloromethane extract liquor merges, and is spin-dried for obtaining 6.1g (yield 55%) whites Foam-like sterling, purity 98.6%, N, N- dicyclohexylurea (DCU) contents are less than 6 μ g/mg.
MS(ESI)m/z 514.3(M/2)。
Step 2 product is detected through nuclear-magnetism.
Isomers content in 2 products therefrom of above-mentioned steps is measured, and former triturate Comparative result is as follows:
A kind of synthetic method of 5 Mivacurium Chloride of embodiment, includes the following steps:
Step 1:Condensation reaction
1.0g E- octyl- 4- alkene -1,8- diacid and 5.3g p-methyl benzenesulfonic acid 3- hydroxypropyl acrylates are added to 50mL ethylene glycol diethyls In ether, 1.7g N, N'- diisopropylcarbodiimides and 1.2g 4-dimethylaminopyridine is then added, reaction 12 is small at 60 DEG C When, the reaction was complete for HPLC detections, 20mL 1mol/L dilute hydrochloric acid is added, reaction is quenched.After liquid separation, organic phase saturated salt solution (50mL × 2) wash twice, anhydrous sodium sulfate drying.It is spin-dried for obtaining compound E- octyl- 4- alkene -1,8- diacid two-to toluene sulphur Acyl propyl ester 2.8g (yield 80%) pale yellowish oil liquid, purity 94.2%.
MS(ESI)m/z 597.5(M+1)。
Step 1 product is detected through nuclear-magnetism and is confirmed.
Step 2:The synthesis of Mivacurium Chloride
By 2.0g E- octyl- 4- alkene -1,8- two-tolysulfonyl of diacid propyl ester, 3.5g (R)-(+) -5'- methoxyl group laudanums Element is added in 100mL dioxane, is heated to 100 DEG C and is flowed back 1 hour, and the reaction was complete for HPLC detections, is cooled to room temperature, mistake Filter, filter cake are washed with 20mL methanol.Resin anion (R.A.) (717 chlorine type) 50g is added into filtrate, stirs 5 hours, filters out tree Fat, filtrate are spin-dried for obtaining yellow foam crude product 4.3g.50mL water and 50mL dichloromethane are added into crude product, stirs liquid separation, Water phase is washed three times with dichloromethane (25mL × 3) successively, and chloroform (10mL × 1) is washed once, and 18g NaCl are then added, and is added two Chloromethanes (100mL × 2) is extracted twice.Dichloromethane extract liquor merges, and is spin-dried for obtaining 2.1g (yield 57%) white foam Sterling, purity 98.7%, N, N'- diisopropyl urea contents are less than 6 μ g/mg.
MS(ESI)m/z 514.3(M/2)。
Step 2 product is detected through nuclear-magnetism.
Isomers content in 2 products therefrom of above-mentioned steps is measured, and former triturate Comparative result is as follows:
Although the embodiments of the present invention has been shown and described above, it is to be understood that above-described embodiment is example Property, it is not considered as limiting the invention, those skilled in the art are not departing from the principle of the present invention and objective In the case of the above embodiments can be changed within the scope of the invention, change, replace and modification.

Claims (10)

1. a kind of Mivacurium Chloride intermediate, which is characterized in that it is bis- propyl propionate of compound E- octyl- 4- alkene -1,8- shown in formula 3, Structural formula is as follows:
In formula 3, X F, Cl, Br, I, methanesulfonyloxy group OMs or tolysulfonyl oxygroup OTos.
2. Mivacurium Chloride intermediate according to claim 1, it is characterised in that:X is Cl or methanesulfonyloxy group.
3. a kind of preparation method of Mivacurium Chloride intermediate as claimed in claim 1 or 2:With E- octyl- 4- alkene -1,8- diacid and formula 2 compoundsFor raw material, condensation reaction generation is carried out, specifically A or B with the following method:
Method A:The E- octyl- 4- alkene -1,8- diacid is sent out in non-protonic solvent, under condensing agent effect with 2 compound of formula Raw reaction is condensed into ester, controls 0~100 DEG C of temperature of reaction system, after reaction, passes through extracting and washing or mashing, concentration Obtain Mivacurium Chloride crude intermediate;
Method B:Reference method A, difference lies in without using condensing agent, but first by E- octyl-s 4- alkene -1,8- diacid and thionyl chloride Reaction becomes carrying out condensation reaction with 2 compound of formula again after acyl chlorides.
4. preparation method according to claim 3, it is characterised in that:The condensing agent is selected from 1- (3- dimethylaminos third Base) -3- ethyl-carbodiimide hydrochlorides EDCl, N, N'- dicyclohexylcarbodiimide DCC and N, two acyl of N'- diisopropyls carbon In imines DIC any one or it is two or more;
The aprotic solvent is selected from ether, ethyl acetate, tetrahydrofuran, dimethyl-tetrahydrofuran, dioxane, methyl- tert fourth In base ether, glycol dimethyl ether, glycol monoethyl ether, ethylene glycol diethyl ether, ethylene glycol monoethyl ether, dichloromethane and chloroform One or more;
Compound shown in the formula 2 is selected from 3- chloropropyl alcohols, 3- iodine propyl alcohol, 3- bromopropyl alcohols, p-methyl benzenesulfonic acid 3- hydroxypropyl acrylates and first One or more of alkyl sulfonic acid 3- hydroxypropyl acrylates.
5. preparation method according to claim 4, it is characterised in that:The aprotic solvent is dichloromethane, acetic acid second One or more of ester and tetrahydrofuran;
2 compound of formula is 3- chloropropyl alcohols and/or Loprazolam 3- hydroxypropyl acrylates.
6. preparation method according to claim 4 or 5, it is characterised in that:The E- octyl- 4- alkene -1,8- diacid and formula 2 Compound mole ratio is 1 ︰, 2~1 ︰ 6;Reaction temperature is controlled at 0~30 DEG C;Reaction time is 0.5~24 hour.
7. a kind of method that Mivacurium Chloride intermediate using described in claims 1 or 22 synthesizes Mivacurium Chloride, steps are as follows:
Mivacurium Chloride intermediate and (R)-(+) -5'- methoxyl group laudanosines in reaction dissolvent, 50~100 DEG C of stirrings 1 of temperature control~ 24 hours, after reaction, Chioro-anion exchange resin, agitation and filtration was added in filtrate in cold filtration, and filtrate is spin-dried for obtaining Then crude product obtains Mivacurium Chloride of the purity 98% or more by extracting concentration;
The reaction dissolvent is selected from least one of acetonitrile, propionitrile, dioxane, 2- butanone and acetone.
8. according to the method described in claim 7, it is characterized in that:When the X in 3 compound of Mivacurium Chloride intermediate formula be F, Cl, Br or when methanesulfonyloxy group, are added sodium iodide and promote reaction.
9. method according to claim 7 or 8, it is characterised in that:The reaction dissolvent is acetonitrile.
10. method according to claim 7 or 8, it is characterised in that:The Mivacurium Chloride intermediate and (R)-(+)- 5'- methoxyl group laudanosine molar ratios are 1:2~1:6;The temperature of the temperature control is 60~90 DEG C;Mixing time is 8~16 hours.
CN201711010252.2A 2017-09-30 2017-10-25 A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride Pending CN108503564A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2017109232667 2017-09-30
CN201710923266 2017-09-30

Publications (1)

Publication Number Publication Date
CN108503564A true CN108503564A (en) 2018-09-07

Family

ID=63375327

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711010252.2A Pending CN108503564A (en) 2017-09-30 2017-10-25 A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride

Country Status (1)

Country Link
CN (1) CN108503564A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232222A (en) * 2018-10-19 2019-01-18 武汉嘉诺康医药技术有限公司 A kind of preparation method of (E)-octyl- 4- alkene -1,8- diacid
CN109942490A (en) * 2019-04-11 2019-06-28 海南斯达制药有限公司 A kind of reference substance of Mivacurium Chloride and preparation method thereof
CN110698398A (en) * 2019-10-31 2020-01-17 武汉嘉诺康医药技术有限公司 Purification method of mikui ammonium chloride
CN111471013A (en) * 2020-05-26 2020-07-31 朗天药业(湖北)有限公司 Mickura ammonium chloride and preparation method of injection thereof
CN112778200A (en) * 2021-01-20 2021-05-11 江苏诚信药业有限公司 Preparation method and application of cisatracurium besilate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181055A1 (en) * 1984-07-18 1986-05-14 The Wellcome Foundation Limited Bis-dimethoxymethyl (trimethoxybenzyl)isoquinolinium salts, their preparation and pharmaceutical compositions containing them
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181055A1 (en) * 1984-07-18 1986-05-14 The Wellcome Foundation Limited Bis-dimethoxymethyl (trimethoxybenzyl)isoquinolinium salts, their preparation and pharmaceutical compositions containing them
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232222A (en) * 2018-10-19 2019-01-18 武汉嘉诺康医药技术有限公司 A kind of preparation method of (E)-octyl- 4- alkene -1,8- diacid
CN109232222B (en) * 2018-10-19 2021-03-23 武汉嘉诺康医药技术有限公司 Preparation method of (E) -octyl-4-ene-1, 8-diacid
CN109942490A (en) * 2019-04-11 2019-06-28 海南斯达制药有限公司 A kind of reference substance of Mivacurium Chloride and preparation method thereof
CN110698398A (en) * 2019-10-31 2020-01-17 武汉嘉诺康医药技术有限公司 Purification method of mikui ammonium chloride
CN111471013A (en) * 2020-05-26 2020-07-31 朗天药业(湖北)有限公司 Mickura ammonium chloride and preparation method of injection thereof
CN112778200A (en) * 2021-01-20 2021-05-11 江苏诚信药业有限公司 Preparation method and application of cisatracurium besilate

Similar Documents

Publication Publication Date Title
CN108503564A (en) A kind of Mivacurium Chloride intermediate and the method using intermediate synthesis Mivacurium Chloride
CN106279074B (en) A kind of compound and preparation method thereof and the purposes in Bu Waxitan is synthesized
CN105418460B (en) Intermediate of pimavanserin and similar compound thereof, and preparation method thereof, and method for preparing pimavanserin and similar compound thereof
CN106432030B (en) A kind of preparation method of Bu Waxitan
CN103588657A (en) Method for producing phenylacetamide compound
CN104144933B (en) The method for preparing 2 cyanophenyl boronic acids and its ester
CN104628679B (en) Bitopertin synthetic method and its intermediate
US9771317B2 (en) Process for preparing lacosamide and related compounds
CN101102996A (en) Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
US9469593B2 (en) Process for preparing cinacalcet hydrochloride
CN110818590A (en) Preparation method of p-hydroxybenzonitrile
CN100427460C (en) Method for synthesis of L-norvaline
CN103193666B (en) The preparation method of 2-amino-3-chloro benzoic ether
CN103288708B (en) The preparation method of 1- aryl -2- indolinone derivative
CN108101860A (en) The preparation method of cis -2,6- thebaines
CN109265385B (en) Synthesis process of chiral catalyst
CN113121597A (en) Method for preparing chlorpyrifos in condensed state
JP5071795B2 (en) Process for producing benzooxathiin compound
JP2594826B2 (en) Method for producing p- or m-hydroxyphenethyl alcohol
CN104987302B (en) N, N diethyl formic acid 4 halogenated methyl 3,5 xylenol ester compounds and preparation method thereof
CN109824536A (en) A kind of preparation method of Otilonium Bromide
CN108046980B (en) Novel synthesis method of 5-bromo-1-pentene
CN114195684B (en) Synthesis method of amino protecting group N-substituted chiral amino acid
CN108424396A (en) A kind of preparation method of light stabilizer TINUVIN 1600
CN103201252A (en) Preparation method of cinacalcet and pharmaceutical salts thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180907